WaferGen Biosystems this week said that it has appointed Donald Huffman as its new chief financial officer.
Huffman was most recently CFO at Asante Solutions, a medical device company developing a drug-delivery pump. Prior to that, he was CFO at Guava Technologies, EndoSonics, Microcide Pharmaceuticals, Celtrix Pharmaceuticals, and Sanderling Ventures, a biomedical venture capital firm.
Hugh Douglas has joined BioCision as chief operating officer.
Douglas most recently led Bridge4Bio, a global business consulting group. Previously, he was managing director and president of Hoefer, a part of Harvard Bioscience. Douglas was also vice president of the West Coast operations for Amersham Biosciences, now a part of GE Healthcare.
The company has also expanded its corporate advisory board. New members include Lori Kunkel, who has served as chief medical officer at Proteolix/Onyx Pharmaceuticals, vice president of clinical development at Xenocor, and has held other senior positions at Genentech, Chiron, and Genitope; and Paul Nowak, currently CEO of Biotix Holdings and previously CEO and president of VWR International.